Goldman Sachs upgraded Amgen (NASDAQ: AMGN) from Neutral to Conviction Buy with a price target of $130.00 (from $100.00). Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE